Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Torrent Australasia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (133)
Cancellation by sponsor (20)
Prescription medicine registration (3)

Date

2024 (7)
2023 (35)
2022 (2)
2021 (3)
2020 (4)
2019 (44)
2012 (20)
2011 (9)
2010 (15)
2008 (17)

Results for "[search-keyword]"

Search

Sponsor content

156 result(s) found, displaying 81 to 90

EZETIMIBE/SIMVASTATIN-WGR 10/80 ezetimibe 10 mg and simvastatin 80 mg tablet blister pack (309773)

15 October 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for EZETIMIBE/SIMVASTATIN-WGR 10/80 ezetimibe 10 mg and simvastatin 80 mg tablet blister pack.
EZETIMIBE/SIMVASTATIN-WGR 10/40 ezetimibe 10 mg and simvastatin 40 mg tablet blister pack (309743)

15 October 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for EZETIMIBE/SIMVASTATIN-WGR 10/40 ezetimibe 10 mg and simvastatin 40 mg tablet blister pack.
EZETIMIBE/SIMVASTATIN-WGR 10/20 ezetimibe 10 mg and simvastatin 20 mg tablet blister pack (309723)

15 October 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for EZETIMIBE/SIMVASTATIN-WGR 10/20 ezetimibe 10 mg and simvastatin 20 mg tablet blister pack.
RESPIKAST 10 montelukast (as sodium) 10 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Torrent Australasia Pty Ltd
MONTELUKAST GH montelukast (as sodium) 5 mg chewable tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Torrent Australasia Pty Ltd
OLANZAPINE TORRENT ODT 5 olanzapine 5 mg orally disintegrating tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Torrent Australasia Pty Ltd
OLANZAPINE TORRENT ODT 10 olanzapine 10 mg orally disintegrating tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Torrent Australasia Pty Ltd
EZESIM, EZETORIN, EZETREE, EZETYR, EZEVYT, EZSIMZA GH, EZTORSI, SIMTOR, SIMTORSI, TORZESIM (Torrent Australasia Pty Ltd)

25 September 2019

Prescription medicine registration

Active ingredients: ezetimibe; simvastatin.
LAMOTRIGINE GENERIC HEALTH lamotrigine 100mg dispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

20 June 2019

Cancellation by sponsor

Requested by Torrent Australasia Pty Ltd
LAMOTRIGINE GENERIC HEALTH lamotrigine 200mg dispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

20 June 2019

Cancellation by sponsor

Requested by Torrent Australasia Pty Ltd

Pages

First page
Previous page
…
Page 5
Page 6
Page 7
Page 8
Current page 9
Page 10
Page 11
Page 12
Page 13
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.